Menu

Image of the Day: Delayed Gratification

Eighty years ago, a Neanderthal femur dating back more than 120,000 years was recovered from a Southwestern Germany cave. Now, the ancient bone reveals new clues about the bedfellows of human ancestors. 

Jul 7, 2017
The Scientist Staff

Hohlenstein-Stadel Cave in Southwestern Germany, where an ancient, 124,000-year-old hominin femur was excavated in 1937

© PHOTO MUSEUM ULM

   In a study published this week (July 4) in Nature Communications, mitochondrial DNA from a Neanderthal femur, unearthed in 1937 from a Southwestern Germany cave, sheds light on the migration and mating patterns of human ancestors.

See “Neanderthal-Human Interbreeding Got an Early Start

124,000-year-old Neanderthal femur

OLEG KUCHAR © PHOTO MUSEUM ULM

    See C. Posth et al., “Deeply divergent archaic mitochondrial genome provides lower time boundary for African gene flow into Neanderthals,” Nature Communications, doi:10.1038/ncomms16046, 2017.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.